Company intelligence / Profile preview

Fountain Life

Naples, Florida, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Fountain Life's centers have enabled early detection of life-threatening, often asymptomatic conditions (including cancer, cardiac, metabolic, and neurodegenerative diseases) in about 14% of its members, supporting actionable, preventive healthcare. The company also aims to deliver stem cell therapies for orthopedic and related conditions, particularly under recent Florida legislation, in partnership with Celularity. No published clinical trial results as Fountain Life is primarily a diagnostics/service provider, not a drug developer.

Therapeutic areas: Metabolic DisordersRheumatologyDermatologyCardiovascularOtherOncologyNeurology
Modalities: DeviceDiagnosticsCell therapyGene therapyRegenerative medicinePersonalized medicine
Industry: Non-Academic Healthcare

Partnerships

Celularity (regenerative/cell therapies)

Beyond the preview

Go deeper on Fountain Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fountain Life.

Explore the full profile